A detailed history of Cwm, LLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 2,431 shares of ZNTL stock, worth $7,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,431
Previous 75 3141.33%
Holding current value
$7,730
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$2.9 - $4.57 $6,832 - $10,766
2,356 Added 3141.33%
2,431 $9,000
Q2 2024

Jul 09, 2024

BUY
$4.09 - $16.13 $147 - $580
36 Added 92.31%
75 $0
Q1 2024

Apr 05, 2024

BUY
$10.83 - $16.49 $422 - $643
39 New
39 $1,000
Q2 2023

Aug 03, 2023

BUY
$17.41 - $30.05 $2,385 - $4,116
137 New
137 $4,000
Q2 2022

Jul 28, 2022

SELL
$17.91 - $52.25 $125 - $365
-7 Closed
0 $0
Q1 2022

Apr 21, 2022

SELL
$41.58 - $80.89 $498 - $970
-12 Reduced 63.16%
7 $0
Q4 2021

Jan 31, 2022

SELL
$66.92 - $84.79 $12,112 - $15,346
-181 Reduced 90.5%
19 $2,000
Q3 2020

Oct 19, 2020

BUY
$27.03 - $47.97 $5,406 - $9,594
200 New
200 $7,000

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $181M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.